AstraZeneca sold its 7.7 percent stake in Moderna for more than $1 billion: Report
New Delhi: AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company's shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna.AstraZeneca and Moderna did not immediately respond to requests...
New Delhi: AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company's shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.
Read also: AstraZeneca, Novavax say tie-up with Serum Institute key to mass production of Covid-19 Vaccines
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd